AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2012
May 8, 2012
30042_dirs_2012-05-08_26087658-998c-4edc-9030-c5f3b9212272.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-05-07
Reporting Person: Solomon Carlyn D (CVP, Critical Care & Vascular)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-07 | Common Stock | F | 881.0000 | $84.9900 | Disposed | 33230.0000 | Direct |
| 2012-05-08 | Common Stock | F | 1174.0000 | $85.4900 | Disposed | 32056.0000 | Direct |
Footnotes
F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 8
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17